L2 L3 and L4 Asthma Drugs Flashcards
Describe short acting beta-2 agonist drugs and their use in asthma treatment.
Short-acting beta-2 agonists such as salbutamol and terbutaline are used in the treatment of acute bronchospasm. Stimulate the relaxation of bronchial smooth muscle. Act within 5-15 mins for 3-6 hours.
First line of treatment for acute relief.
given as needed.
Increased use indicates lack of asthma control.
Doseage forms include metered dose inhaler, dry powder inhaler, nebuliser, oral liquid and injection.
Safe to use in pregnancy.
Describe non-steroidal preventers.
CROMOLYNS: Have no bronchodilator effect. Used to decrease airway hyperactivity over time (prevent late-phase of asthma). Preventative effect may take up to 1 month.
LEUKOTRIENE ANTAGONISTS: Leukotrienes are implicated in bronchoconstriction and oedema. Leukotriene antagonists are administered orally, are long-acting with a slow onset of action. They reduce airway inflammation.
Describe corticosteroid preventers.
Inhaled corticosteroids such as betamethasone reduce inflammation and bronchial hyperactivity over time, but have some systemic adverse effects.
What is theophylline?
Orally administered bronchodilator used for severe airway obstruction. Pharmacokinetic variability means patients require TDM. LABA.
Which preventer medication should be the initial choice in pregnancy?
budesonide.
What is the general mechanism of action of beta-2 agonists and theophylline?
- activate adenylyl cyclase which increases the production of cAMP in bronchial smooth muscle
- cAMP activates PKA
- PKA phosphorylates intracellular proteins, and this cascade leads to smooth muscle relaxation and bronchodilation.
Apart from directly relaxing bronchial smooth muscle through increasing cAMP concentration, what other effects do short acting beta-2 agonists have?
Inhibit the release of bronchoconstricting substances from mast cells, and may also inhibit microvascular leakage and increase mucociliary transport.
Describe long acting beta-2 agonists, including their use, 2 examples and comparison of 2 drugs.
Onset of action is 10-30 mins after administration, so not used for acute relief of symptoms. Long duration of action (more than 12 hours).
Eg Eformoterol and Salmeterol, which both come as Dry Powder Inhalers. Eformoterol has a faster onset of action than salmeterol.
These drugs are not recommended as sole asthma treatment as they do not address underlying airway inflammation.
What is a rare adverse effect of long-acting beta-2 agonist use in asthma?
1% chance of paradoxical bronchoconstriction due to propellants or dispersants in inhalers. This effect is worsened by the longer onset of action.
What are the indications for use of long acting beta-2 agonists?
Maintenance treatment of asthma (especially nocturnal) in patients receiving corticosteroids.
Adjunctive therapy in patients whose asthma is inadequately controlled by glucocorticoids.
Protection against exercise-induced asthma (give at least 30 mins before exercise), but effectiveness may decline with regular use..
Maintenance treatment of COPD
Can eformoterol or salmeterol be used in pregnancy?
Yes, however experience in pregnancy is limited
What is the mechanism of action of salmeterol?
Side chain of the molecule binds to a specific site of the beta-2 adrenergic receptor that results in prolonged receptor activation.
What is the mechanism of action of eformoterol?
Enters the lipid bilayer of the cell membrane, from which it gradually leeches out and is thus available over a long period of time to stimulate the beta-2 adrenoreceptor.
What are the effects of medications such as propanalol in asthmatics?
These medications are beta-2 receptor ANTAGONISTS, and prevent bronchodilation. This can cause wheezing, and may precipitate an acute asthmatic attack by interfering with the effect of endogenous adrenaline (beta-2 agonist)
List 5 side effects of beta-2 agonists.
Tremor (most common SE) Tachycardia headache hyperglycaemia hypokalemia
How do beta-2 agonists cause tremor?
Direct stimulation of beta-2 receptors in skeletal muscle. Occurs frequently with oral beta-2 agonists, but rarely with inhaled ones.
How do beta-2 agonists cause tachycardia?
Stimulation of beta-2 receptors can cause vasodilation and reflex tachycardia (some beta 2 receptors present in ventricles and atria of heart. Cardiac symptoms are rare in patients on normal doses. In high doses, selective beta-2 agonists lose selectivity and may act on other adregenergic receptors outside the lungs.
What is hypokalemia, and how is it exacerbated?
Hyperkalemia is the presence of excess potassium in the blood. It may occur with high doses of beta-2 agonists, and may be exacerbated by concomitant treatment with methylxanthines, corticosteroids, diuretics and by hypoxia.
How dose tolerance to beta-2 agonists occur? What is the result of this, and how can tolerance be minimised?
Tolerance is the result of beta-2 receptor down-regulation due to chronic use of beta-2 agonists. This results in the shortening of duration of bronchodilation, however this is not clinically important to the short-acting drugs.
Steroids inhibit beta receptor downregulation. Glucocorticoids stimulate increased transcription of the gene for the beta-receptor.
What is an example of an anticholinergic bronchodilator?
Ipatropium (muscurinic receptor antagonist)
Compare ipatropium to it’s parent molecule.
Ipratropium is a derivative of atropine. It is a charged molecule so does not cross BBB, and is not well absorbed into the circulation and thus has minimal action at systemic muscurinic receptors.
Unlike atropine, it does not inhibit mucocilliary clearance (so less accumulation of secretions in lower airways)
Describe the mechanism of action of ipatropium?
Blocks the action of Ach at muscurinic receptors, inhibiting bronchomotor tone (promoting bronchodilation). Ach is an endogenous bronchoconstrictor.
Inhibits mucous secretion.
onset of action 30-60 minutes.
Muscurinic receptors are part of the parasympathetic pathway of bronchospasm, and so ipratropium is useful in patients who are intolerant to sympathomimetics or methylxanthines.
In severe asthma, ipratropium enhances bronchodilation produced by beta-2 agonists.